ROBERT C. YOUNG, M.D., F.A.C.P.; JOHN E. BENNETT, M.D., F.A.C.P.; GLENN W. GEELHOED, M.D.; ARTHUR S. LEVINE, M.D.
▸Requests for reprints should be addressed to Robert C. Young, M.D., Medicine Branch, National Cancer Institute, Bethesda, MD 20014.
YOUNG R., BENNETT J., GEELHOED G., LEVINE A.; Fungemia with Compromised Host Resistance: A Study of 70 Cases. Ann Intern Med. 1974;80:605-612. doi: 10.7326/0003-4819-80-5-605
Download citation file:
Published: Ann Intern Med. 1974;80(5):605-612.
Seventy patients with antemortem fungemia were studied. The findings and subsequent course of the patients allowed these episodes of fungemia to be related to disseminated fungal infection (44 patients), transient catheter-induced fungemia (8 patients), or clinically insignificant fungemia (18 patients). Candida fungemias were associated with disseminated mycosis when the patients were immunosuppressed, leukopenic, grew Candida organisms from three or more other sites, or did not have a contaminated intravenous catheter. Noncandida fungemias were associated with disseminated fungal infection when the patients had multiple other positive sites, grew fungus out of more than one blood culture, and had fungemias with recognized pathogens. Sixty-three percent of the patients had either autopsy-proved or clinically diagnosed disseminated mycoses. Fungemia in patients with compromised host resistance, especially lymphoreticular or hematopoietic malignancies, is frequently associated with disseminated fungal infection.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, Pulmonary/Critical Care, Multi-Organ Failure and Sepsis.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only